NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Practice this question and more.

Which drug is recommended for breast cancer prophylaxis in postmenopausal females?

Tamoxifen
Raloxifene
Fulvestrant
Trastuzumab

The correct answer is: Raloxifene

Postmenopausal females are women who have completed menopause and are no longer able to bear children. When it comes to breast cancer prophylaxis (preventative measures), it is recommended that postmenopausal females take a medication called Raloxifene. This drug specifically targets estrogen receptors in the breast tissue, reducing the risk of breast cancer development. Option A, Tamoxifen, is another commonly prescribed drug for breast cancer prevention but is more commonly used in premenopausal women. Options C and D, Fulvestrant and Trastuzumab, are both used for the treatment of breast cancer, not prevention. Therefore, they would not be the recommended choice for postmenopausal females looking to prevent breast cancer.